What we measure
Patient tests use FDA-approved genetic markers — clinical markers, not a research-only dump. We do not publish a gene-by-gene catalogue here until medical has signed off a public list.
THE GENE RETAIL COMPANY
We stay inside FDA-approved markers, CPIC guidelines, and Indian-population context. AI helps curate multi-marker reports; it does not replace a clinician.
Patient tests use FDA-approved genetic markers — clinical markers, not a research-only dump. We do not publish a gene-by-gene catalogue here until medical has signed off a public list.
Allele frequencies differ across populations. Panels copied from Western catalogues miss variants that matter here. Our PGx work is built for Indian-population context.
Reports use CPIC clinical practice guidelines so a clinician sees gene–drug notes they can act on. The report does not replace clinical judgement.
AI helps curate multi-marker findings into one clinician-ready report. It does not diagnose, and it does not operate without a clinician in the loop.
Each sample is tracked by a unique QR code with personal information delinked. Samples are securely destroyed 90 days after the specific genetic test report. Research or commercial use of a sample is opt-in.
Full sample, QR, and destruction rules live in Privacy.
For clinicians